Lv51
1200 积分 2024-11-12 加入
Dibromocarbene addition to bicyclo[1.1.0]butanes: A facile route to substituted bicyclo[1.1.1]pentanes
6天前
已完结
The expanding landscape of GLP-1 medicines
10天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
15天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
15天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
15天前
已完结
Oral GLP-1 receptor agonists: competition for efficacy and tolerability
15天前
已关闭
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues?
20天前
已关闭
Impact of GLP-1 receptor agonists on gastrointestinal function and symptoms
21天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
28天前
已完结
Vav1 promotes inflammation and neuronal apoptosis in cerebral ischemia/reperfusion injury by upregulating microglial and NLRP3 inflammasome activation
30天前
已完结
皖公网安备34019202002308
